Companies:
49,817
Total Market Cap:
139333354065608.02
Global Rank
#10432
Country Rank
#36
Market Cap
877.09 M
Price
33.09
Change (%)
0.18%
Volume
3,878
Revenio Group Oyj's latest marketcap:
877.09 M
As of 07/05/2025, Revenio Group Oyj's market capitalization has reached $877.09 M. According to our data, Revenio Group Oyj is the 10432th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 877.09 M |
| Revenue (ttm) | 125.19 M |
| Net Income (ttm) | 22.49 M |
| Shares Out | 26.6 M |
| EPS (ttm) | 0.84 |
| Forward PE | 30.85 |
| Ex-Dividend Date | 04/11/2025 |
| Earnings Date | 08/07/2025 |
Market Cap Chart
Data Updated: 07/05/2025
Revenio Group Oyj's yearly market capitalization.
Revenio Group Oyj has seen its market value grow from €115.37 M to €877.09 M since 2014, representing a total increase of 660.23% and an annual compound growth rate (CAGR) of 21.28%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €877.09 M | 5.75% | 10432 |
| 12/30/2024 | €706.92 M | -2.12% | 10540 |
| 12/29/2023 | €722.26 M | -29.6% | 9983 |
| 12/30/2022 | €1.03 B | -30.47% | 7819 |
| 12/30/2021 | €1.48 B | 10.59% | 6837 |
| 12/30/2020 | €1.33 B | 91.88% | 6026 |
| 12/30/2019 | €695.4 M | 131.08% | 7932 |
| 12/28/2018 | €300.94 M | 4.81% | 11022 |
| 12/29/2017 | €287.13 M | 18.13% | 12249 |
| 12/30/2016 | €243.06 M | 6.92% | 11852 |
Company Profile
About Revenio Group Oyj
Revenio Group Oyj specializes in ophthalmological devices and software solutions for diagnosing conditions such as glaucoma, macular degeneration, and diabetic retinopathy. The company operates in the United States, Finland, and internationally.
Product Portfolio
- iCare Tonometers: Includes IC100, IC200, ST500, TONOVET Pro, and TONOVET Plus for intraocular pressure measurement.
- iCare HOME2: A home-use intraocular pressure monitor.
- iCare Sensors: Accessories for hygienic and painless IOP measurement.
- Fundus Imaging Systems: iCare EIDON AF, EIDON, and EIDON UWF F for retinal imaging.
- iCare COMPASS: A device for visual field examination and confocal fundus imaging.
- iCare ILLUME: AI-powered early detection for diabetic retinopathy, macular degeneration, and glaucoma.
- iCare CLINIC: Cloud-based service for IOP data storage and analysis.
- Oculo: An eye care software platform integrating telehealth, remote monitoring, and analytics.
Company Background
Founded in 2001, Revenio Group Oyj is headquartered in Vantaa, Finland.
Frequently Asked Questions
-
What is Revenio Group Oyj's (HEL-REG1V) current market cap?As of 07/05/2025, Revenio Group Oyj (including the parent company, if applicable) has an estimated market capitalization of $877.09 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Revenio Group Oyj (HEL-REG1V) rank globally by market cap?Revenio Group Oyj global market capitalization ranking is approximately 10432 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.